Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Europe Biodefense Market By Product (Anthrax, Smallpox, Botulism, Radiation/nuclear, and Other Products), By Country, Industry Analysis and Forecast, 2020 - 2026

Published by KBV Research Product code 988238
Published Content info 68 Pages
Delivery time: 1-2 business days
Price
Back to Top
Europe Biodefense Market By Product (Anthrax, Smallpox, Botulism, Radiation/nuclear, and Other Products), By Country, Industry Analysis and Forecast, 2020 - 2026
Published: January 29, 2021 Content info: 68 Pages
Description

The Europe Biodefense Market would witness market growth of 5.4% CAGR during the forecast period (2020-2026).

Bioterrorism refers to the utilization of biological agents that are damaging the mankind. Biodefense means the usage of medical steps in order to save mankind from bioterrorism, including interventions like drugs and vaccinations. Moreover, research and public health preparations have seen development to counter biological attacks.

Over the last few years, genetic engineering and biotechnology have seen massive technological advancements, which have offered innovative ways to address these deadly and naturally occurring viruses that can be re-designed to create additional harm. Also, there is the easy availability of these organisms, which makes biodefense a significant aspect for countries across the globe. To carry out bioterrorism, various biological agents have been used such as botulism, anthrax, and chemical & nuclear agents, causing severe destruction.

The biodefense market is still in the initial phase. The governments in emerging and developed countries are taking several initiatives that ensure the safety of the population. Various governments are proposing programs that include storing vaccines and biodefense machines used on account of a sudden bioterrorism attack.

Based on Product, the market is segmented into Anthrax, Smallpox, Botulism, Radiation/nuclear, and Other Products. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Xoma Corporation, Altimmune, Inc., Emergent BioSolutions, Inc., Dynavax Technologies Corporation, SIGA Technologies, Inc., Elusys Therapeutics, Inc., Ichor Holdings, Ltd., Cleveland BioLabs, Inc., Bavarian Nordic A/S and Alnylam Pharmaceuticals, Inc.

Scope of the Study

Market Segmentation:

By Product

  • Anthrax
  • Smallpox
  • Botulism
  • Radiation/nuclear,
  • Other Products

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Xoma Corporation
  • Altimmune, Inc.
  • Emergent BioSolutions, Inc.
  • Dynavax Technologies Corporation
  • SIGA Technologies, Inc.
  • Elusys Therapeutics, Inc.
  • Ichor Holdings, Ltd.
  • Cleveland BioLabs, Inc.
  • Bavarian Nordic A/S
  • Alnylam Pharmaceuticals, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Biodefense Market, by Product
    • 1.4.2 Europe Biodefense Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 Recent Industry Wide Strategic Developments
    • 3.1.1 Partnerships, Collaborations and Agreements
    • 3.1.2 Approvals
    • 3.1.3 Acquisition and Mergers
  • 3.2 Top Winning Strategies
    • 3.2.1 Key Leading Strategies: Percentage Distribution (2016-2020)
    • 3.2.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Jul - 2020, Jul) Leading Players

Chapter 4. Europe Biodefense Market by Product

  • 4.1 Europe Anthrax Market by Country
  • 4.2 Europe Smallpox Market by Country
  • 4.3 Europe Botulism Market by Country
  • 4.4 Europe Radiation/nuclear Market by Country
  • 4.5 Europe Other Product Market by Country

Chapter 5. Europe Biodefense Market by Country

  • 5.1 Germany Biodefense Market
    • 5.1.1 Germany Biodefense Market by Product
  • 5.2 UK Biodefense Market
    • 5.2.1 UK Biodefense Market by Product
  • 5.3 France Biodefense Market
    • 5.3.1 France Biodefense Market by Product
  • 5.4 Russia Biodefense Market
    • 5.4.1 Russia Biodefense Market by Product
  • 5.5 Spain Biodefense Market
    • 5.5.1 Spain Biodefense Market by Product
  • 5.6 Italy Biodefense Market
    • 5.6.1 Italy Biodefense Market by Product
  • 5.7 Rest of Europe Biodefense Market
    • 5.7.1 Rest of Europe Biodefense Market by Product

Chapter 6. Company Profiles

  • 6.1 Xoma Corporation
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Regional Analysis
    • 6.1.4 Research & Development Expense
  • 6.2 Altimmune, Inc.
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Research & Development Expense
    • 6.2.4 Recent strategies and developments:
      • 6.2.4.1 Acquisition and Mergers:
      • 6.2.4.2 Partnerships, Collaborations, and Agreements:
  • 6.3 Emergent BioSolutions, Inc.
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Research & Development Expense
    • 6.3.4 Recent strategies and developments:
      • 6.3.4.1 Acquisition and Mergers:
      • 6.3.4.2 Partnerships, Collaborations, and Agreements:
  • 6.4 Dynavax Technologies Corporation
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Research & Development Expense
  • 6.5 SIGA Technologies, Inc.
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Research & Development Expense
    • 6.5.4 Recent strategies and developments:
      • 6.5.4.1 Partnerships, Collaborations, and Agreements:
      • 6.5.4.2 Approvals:
  • 6.6 Elusys Therapeutics, Inc.
    • 6.6.1 Company Overview
    • 6.6.2 Recent strategies and developments:
      • 6.6.2.1 Approvals:
  • 6.7 Ichor Holdings, Ltd.
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Regional Analysis
    • 6.7.4 Research & Development Expense
    • 6.7.5 Recent strategies and developments:
      • 6.7.5.1 Partnerships, Collaborations, and Agreements:
  • 6.8 Cleveland BioLabs, Inc.
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Research & Development Expense
    • 6.8.4 Recent strategies and developments:
      • 6.8.4.1 Partnerships, Collaborations, and Agreements:
  • 6.9 Bavarian Nordic A/S
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Regional Analysis
    • 6.9.4 Research & Development Expense
    • 6.9.5 Recent strategies and developments:
      • 6.9.5.1 Partnerships, Collaborations, and Agreements:
      • 6.9.5.2 Approvals:
  • 6.10. Alnylam Pharmaceuticals, Inc.
    • 6.10.1 Company Overview
    • 6.10.2 Financial Analysis
    • 6.10.3 Research & Development Expense

LIST OF TABLES

  • TABLE 1 Europe Biodefense Market, 2016 - 2019, USD Million
  • TABLE 2 Europe Biodefense Market, 2020 - 2026, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Biodefense Market
  • TABLE 4 Approvals- Biodefense Market
  • TABLE 5 Acquisition and Mergers- Biodefense Market
  • TABLE 6 Europe Biodefense Market by Product, 2016 - 2019, USD Million
  • TABLE 7 Europe Biodefense Market by Product, 2020 - 2026, USD Million
  • TABLE 8 Europe Anthrax Market by Country, 2016 - 2019, USD Million
  • TABLE 9 Europe Anthrax Market by Country, 2020 - 2026, USD Million
  • TABLE 10 Europe Smallpox Market by Country, 2016 - 2019, USD Million
  • TABLE 11 Europe Smallpox Market by Country, 2020 - 2026, USD Million
  • TABLE 12 Europe Botulism Market by Country, 2016 - 2019, USD Million
  • TABLE 13 Europe Botulism Market by Country, 2020 - 2026, USD Million
  • TABLE 14 Europe Radiation/nuclear Market by Country, 2016 - 2019, USD Million
  • TABLE 15 Europe Radiation/nuclear Market by Country, 2020 - 2026, USD Million
  • TABLE 16 Europe Other Product Market by Country, 2016 - 2019, USD Million
  • TABLE 17 Europe Other Product Market by Country, 2020 - 2026, USD Million
  • TABLE 18 Europe Biodefense Market by Country, 2016 - 2019, USD Million
  • TABLE 19 Europe Biodefense Market by Country, 2020 - 2026, USD Million
  • TABLE 20 Germany Biodefense Market, 2016 - 2019, USD Million
  • TABLE 21 Germany Biodefense Market, 2020 - 2026, USD Million
  • TABLE 22 Germany Biodefense Market by Product, 2016 - 2019, USD Million
  • TABLE 23 Germany Biodefense Market by Product, 2020 - 2026, USD Million
  • TABLE 24 UK Biodefense Market, 2016 - 2019, USD Million
  • TABLE 25 UK Biodefense Market, 2020 - 2026, USD Million
  • TABLE 26 UK Biodefense Market by Product, 2016 - 2019, USD Million
  • TABLE 27 UK Biodefense Market by Product, 2020 - 2026, USD Million
  • TABLE 28 France Biodefense Market, 2016 - 2019, USD Million
  • TABLE 29 France Biodefense Market, 2020 - 2026, USD Million
  • TABLE 30 France Biodefense Market by Product, 2016 - 2019, USD Million
  • TABLE 31 France Biodefense Market by Product, 2020 - 2026, USD Million
  • TABLE 32 Russia Biodefense Market, 2016 - 2019, USD Million
  • TABLE 33 Russia Biodefense Market, 2020 - 2026, USD Million
  • TABLE 34 Russia Biodefense Market by Product, 2016 - 2019, USD Million
  • TABLE 35 Russia Biodefense Market by Product, 2020 - 2026, USD Million
  • TABLE 36 Spain Biodefense Market, 2016 - 2019, USD Million
  • TABLE 37 Spain Biodefense Market, 2020 - 2026, USD Million
  • TABLE 38 Spain Biodefense Market by Product, 2016 - 2019, USD Million
  • TABLE 39 Spain Biodefense Market by Product, 2020 - 2026, USD Million
  • TABLE 40 Italy Biodefense Market, 2016 - 2019, USD Million
  • TABLE 41 Italy Biodefense Market, 2020 - 2026, USD Million
  • TABLE 42 Italy Biodefense Market by Product, 2016 - 2019, USD Million
  • TABLE 43 Italy Biodefense Market by Product, 2020 - 2026, USD Million
  • TABLE 44 Rest of Europe Biodefense Market, 2016 - 2019, USD Million
  • TABLE 45 Rest of Europe Biodefense Market, 2020 - 2026, USD Million
  • TABLE 46 Rest of Europe Biodefense Market by Product, 2016 - 2019, USD Million
  • TABLE 47 Rest of Europe Biodefense Market by Product, 2020 - 2026, USD Million
  • TABLE 48 Key Information -Xoma Corporation
  • TABLE 49 Key Information - Altimmune, Inc.
  • TABLE 50 Key Information - Emergent BioSolutions, Inc.
  • TABLE 51 Key Information - Dynavax Technologies Corporation
  • TABLE 52 Key Information - SIGA Technologies, Inc.
  • TABLE 53 key information - Elusys Therapeutics, Inc.
  • TABLE 54 key Information - Ichor Holdings, Ltd.
  • TABLE 55 Key Information - Cleveland BioLabs, Inc.
  • TABLE 56 key information - Bavarian Nordic A/S
  • TABLE 57 Key Information - Alnylam Pharmaceuticals, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Key Leading Strategies: Percentage Distribution (2016-2020)
  • FIG 3 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Jul - 2020, Jul) Leading Players
  • FIG 4 Recent strategies and developments: Altimmune, Inc.
  • FIG 5 Recent strategies and developments: Emergent BioSolutions, Inc.
Back to Top